Agabio, R, Sinclair, JM, Addolorato, G, et al. (2018) Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. Lancet Psychiatry, 5: 957–60.
Amato, L, Minozzi, S, Davoli, M (2011) Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database of Systematic Reviews, 6: CD008537.
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (4th edn text revision) . APA.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (5th edn) . American Psychiatric Publishing.
Benson, G, McPherson, A, Reid, S (2012) An alcohol withdrawal tool for use in hospitals. Nursing Times, 108: 15–7.
Bush, K, Kivlahan, DR, McDonell, MB, et al. (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Archives of Internal Medicine, 158: 1789–95.
Carra, G, Johnson, S (2009) Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. Social Psychiatry and Psychiatric Epidemiology, 44: 429–47.
Chiesa, A, Serretti, A (2014) Are mindfulness-based interventions effective for substance use disorders? A systematic review of the evidence. Substance Use & Misuse, 49: 492–512.
Das, AK, Corrado, OJ, Kyerematen, E, et al. (2009) Do doctors understand alcohol units? Clinical Medicine, 9: 525–7.
Das, AK, Corrado, OJ, Sawicka, Z, et al. (2014) Junior doctors’ understanding of alcohol units remains poor. Clinical Medicine, 14: 141–4.
Davis, LL, Wisniewski, SR, Howland, RH, et al. (2010) Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug and Alcohol Dependence, 107: 161–70.
De Beaurepaire, R, Sinclair, JM, Heydtmann, M, et al. (2018) The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective. Frontiers in Psychiatry, 9: 708.
Department of Health (2016a) UK Chief Medical Officers' Low Risk Drinking Guidelines. .
Department of Health (2016b) Alcohol Guidelines Review – Report from the Guidelines Development Group to the UK Chief Medical Officers. Department of Health.
Goodwin, G, Haddad, P, Ferrier, I, et al. (2016) Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30: 495–53.
Haber, P, Lintzeris, N, Proude, E, et al. (2009) Guidelines for the Treatment of Alcohol Problems. University of Sydney.
Hasin, DS, Stinson, FS, Ogburn, E, et al. (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64: 830–42.
Howland, RH, Rush, AJ, Wisniewski, SR, et al. (2009) Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug and Alcohol Dependence, 99: 248–60.
Jonas, DE, Amick, HR, Feltner, C, et al. (2014) Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA, 311: 1889–900.
Kaner, EF, Wutzke, S, Saunders, JB, et al. (2001) Impact of alcohol education and training on general practitioners’ diagnostic and management skills: findings from a World Health Organization collaborative study. Journal of Studies on Alcohol, 62: 621–7.
Kaner, EF, Beyer, FR, Muirhead, C, et al. (2018) Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews, 2: CD004148.
King, EA, Baldwin, DS, Sinclair, JM, et al. (2001) The Wessex Recent In-Patient Suicide Study, 1: case–control study of 234 recently discharged psychiatric patient suicides. British Journal of Psychiatry, 178: 531–6.
Lingford-Hughes, AR, Welch, S, Peters, L, et al. (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology, 26: 899–952.
McHugh, RK, Hearon, BA, Otto, MW (2010) Cognitive behavioral therapy for substance use disorders. Psychiatric Clinics, 33: 511–25.
Michie, S, Whittington, C, Hamoudi, Z, et al. (2012) Identification of behaviour change techniques to reduce excessive alcohol consumption. Addiction, 107: 1431–40.
Minozzi, S, Amato, L, Vecchi, S, et al. (2010) Anticonvulsants for alcohol withdrawal. Cochrane Database of Systematic Reviews, 3: CD005064.
Nadkarni, A, Endsley, P, Bhatia, U, et al. (2017) Community detoxification for alcohol dependence: a systematic review. Drug and Alcohol Review, 36: 389–99.
Nesvåg, R, Knudsen, GP, Bakken, IJ, et al. (2015) Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. Social Psychiatry and Psychiatric Epidemiology, 50: 1267–76.
National Institute for Health and Care Excellence (2010) Alcohol Use Disorders: Diagnosis and Clinical Management of Alcohol-Related Physical Complications . NICE.
National Institute for Health and Care Excellence (2011) Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking (High-Risk Drinking) and Alcohol Dependence . NICE.
National Institute for Health and Care Excellence (2014) Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence . NICE.
Nutt, DJ, Rehm, J (2014) Doing it by numbers: a simple approach to reducing the harms of alcohol. Journal of Psychopharmacology, 28: 3–7.
Paton, C, Chee, S, Drummond, C, et al. (2015) Medically assisted withdrawal from alcohol: an audit of practice in acute adult psychiatric wards in the UK conducted by the Prescribing Observatory for Mental Health (POMH-UK). Journal of Psychopharmacology, 29(issue 8 suppl): A109.
Rehm, J, Shield, K, Gmel, G, et al. (2013) Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. European Neuropsychopharmacology, 23: 89–97.
Rollnick, S, Miller, WR (1995) What is motivational interviewing? Behavioural and Cognitive Psychotherapy, 23: 325–34.
Saunders, JB, Aasland, OG, Babor, TF, et al. (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction, 88: 791–804.
Shields, AL, Caruso, JC (2004) A reliability induction and reliability generalization study of the CAGE questionnaire. Educational and Psychological Measurement, 64: 254–70.
Sinclair, JMA, Latifi, AH, Latifi, AW (2008) Co-morbid substance misuse in psychiatric inpatients: prevalence and association with length of inpatient stay. Journal of Psychopharmacology, 22: 92–8.
Sinclair, J, Searle, E (2016a) Can student health professionals accurately estimate alcohol content in commonly occurring drinks? Therapeutic Advances in Psychopharmacology, 6: 256–62.
Sinclair, JM, Chambers, SE, Shiles, CJ, et al. (2016b) Safety and tolerability of pharmacological treatment of alcohol dependence: comprehensive review of evidence. Drug Safety, 39: 627–45.
Sinclair, J, Vaccari, E, Tiwari, A, et al. (2019a) Impact of personal alcohol consumption on aspects of medical student alcohol-related competencies. Alcohol and Alcoholism, 54: 325–30.
Sinclair, J, McCann, M, Sheldon, E, et al. (2019b) The acceptability of addressing alcohol consumption as a modifiable risk factor for breast cancer: a mixed method study within breast screening services and symptomatic breast clinics. BMJ Open, 9: e027371.
Sullivan, JT, Sykora, K, Schneiderman, J, et al. (1989) Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). British Journal of Addiction, 84: 1353–7.
Swartz, MS, Wagner, HR, Swanson, JW, et al. (2008) The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study. Schizophrenia Research, 100: 39–52.
Thomson, AD, Marshall, EJ (2013) BNF recommendations for the treatment of Wernicke's encephalopathy: lost in translation? Alcohol and Alcoholism, 48: 514–5.
Toftdahl, NG, Nordentoft, M, Hjorthøj, C (2016) Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Social Psychiatry and Psychiatric Epidemiology, 51: 129–40.
Treasure, J (2004) Motivational interviewing. Advances in Psychiatric Treatment, 10: 331–7.
Weaver, T, Madden, P, Charles, V, et al. (2003) Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183: 304–13.
World Health Organization (1992) ICD-10: International Statistical Classification of Diseases and Related Health Problems (Tenth Revision). WHO.
World Health Organization (2018) Global Status Report on Alcohol and Health 2018. WHO.